XCSE
DEMANT
Market cap8.50bUSD
Jul 11, Last price
263.60DKK
1D
-2.23%
1Q
18.53%
Jan 2017
114.66%
Name
Demant A/S
Chart & Performance
Profile
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment provides headsets for collaborative work and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 22,419,000 -0.11% | 22,443,000 13.89% | 19,705,000 7.16% | |||||||
Cost of revenue | 18,114,000 | 18,345,000 | 16,620,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 4,305,000 | 4,098,000 | 3,085,000 | |||||||
NOPBT Margin | 19.20% | 18.26% | 15.66% | |||||||
Operating Taxes | 824,000 | 839,000 | 651,000 | |||||||
Tax Rate | 19.14% | 20.47% | 21.10% | |||||||
NOPAT | 3,481,000 | 3,259,000 | 2,434,000 | |||||||
Net income | 2,387,000 32.98% | 1,795,000 -13.78% | 2,082,000 -17.15% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (2,301,000) | (846,000) | (1,840,000) | |||||||
BB yield | 3.98% | 1.28% | 4.23% | |||||||
Debt | ||||||||||
Debt current | 1,090,000 | 2,238,000 | 7,212,000 | |||||||
Long-term debt | 17,362,000 | 14,902,000 | 10,244,000 | |||||||
Deferred revenue | 812,000 | 635,000 | 501,000 | |||||||
Other long-term liabilities | 674,000 | 862,000 | 741,000 | |||||||
Net debt | 17,340,000 | 16,002,000 | 14,468,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 4,080,000 | 4,335,000 | 2,622,000 | |||||||
CAPEX | (576,000) | (846,000) | (924,000) | |||||||
Cash from investing activities | (1,828,000) | (1,787,000) | (3,328,000) | |||||||
Cash from financing activities | (2,239,000) | (2,441,000) | 934,000 | |||||||
FCF | 3,109,000 | 7,569,000 | (4,455,000) | |||||||
Balance | ||||||||||
Cash | 1,112,000 | 1,138,000 | 1,130,000 | |||||||
Long term investments | 1,858,000 | |||||||||
Excess cash | 15,850 | 2,002,750 | ||||||||
Stockholders' equity | 124,000 | 9,419,000 | 8,562,000 | |||||||
Invested Capital | 26,811,000 | 25,273,150 | 22,566,250 | |||||||
ROIC | 13.37% | 13.62% | 11.96% | |||||||
ROCE | 15.69% | 15.81% | 12.25% | |||||||
EV | ||||||||||
Common stock shares outstanding | 218,970 | 223,130 | 226,010 | |||||||
Price | 264.20 -10.74% | 296.00 53.73% | 192.55 -42.54% | |||||||
Market cap | 57,851,874 -12.41% | 66,046,480 51.77% | 43,518,226 -44.70% | |||||||
EV | 75,271,874 | 82,211,480 | 57,987,226 | |||||||
EBITDA | 5,740,000 | 5,432,000 | 4,261,000 | |||||||
EV/EBITDA | 13.11 | 15.13 | 13.61 | |||||||
Interest | 652,000 | 559,000 | 195,000 | |||||||
Interest/NOPBT | 15.15% | 13.64% | 6.32% |